AVALO THERAPEUTICS INC

Ticker: AVTX CUSIP: 05338F306 Class: COM NEW

VANGUARD GROUP INC's Holding History (CIK: 0000102909)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025

Shares 804,084 Value ($000) $14,602 Avg Close $16.88 Range $12.41 - $20.72

Q3 2025

Shares 692,637 Value ($000) $8,803 Avg Close $8.60 Range $4.61 - $14.07

Q2 2025

Shares 166,941 Value ($000) $833 Avg Close $4.67 Range $3.39 - $8.37

Q1 2025

Shares 166,941 Value ($000) $1,337 Avg Close $7.58 Range $5.99 - $11.23

Q4 2024

Shares 165,801 Value ($000) $1,232 Avg Close $10.69 Range $7.34 - $16.00

Q3 2024

Shares 10,368 Value ($000) $98 Avg Close $10.31 Range $6.84 - $13.30

Q2 2024

Shares 10,368 Value ($000) $129 Avg Close $12.97 Range $8.92 - $22.47

Period	Shares	Value ($000)	Average Close	Price Range
Q4 2025	804,084	$14,602	$16.88	$12.41 - $20.72
Q3 2025	692,637	$8,803	$8.60	$4.61 - $14.07
Q2 2025	166,941	$833	$4.67	$3.39 - $8.37
Q1 2025	166,941	$1,337	$7.58	$5.99 - $11.23
Q4 2024	165,801	$1,232	$10.69	$7.34 - $16.00
Q3 2024	10,368	$98	$10.31	$6.84 - $13.30
Q2 2024	10,368	$129	$12.97	$8.92 - $22.47